Geneos Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Buy
3,402
+1,615
+90% +$109K ﹤0.01% 1052
2026
Q2
$114K Sell
1,787
-2,491
-58% -$164K ﹤0.01% 1171
2026
Q1
$305K Sell
4,278
-996
-19% -$78.5K 0.01% 827
2025
Q4
$433K Sell
5,274
-20
-0.4% -$1.56K 0.01% 707
2025
Q3
$398K Sell
5,294
-1,646
-24% -$123K 0.01% 720
2025
Q2
$514K Buy
6,940
+4,367
+170% +$304K 0.01% 701
2025
Q1
$208K Buy
2,573
+70
+3% +$6.02K 0.01% 895
2024
Q4
$196K Buy
+2,503
New +$213K 0.01% 839

Other funds holding GEHC

Geneos Wealth Management's GEHC Position: Q3 2026 in Review

Geneos Wealth Management increased its GE HealthCare (GEHC) stake by 90% in Q3 2026, buying an estimated $109K and bringing the position to 3,402 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Geneos Wealth Management first reported a position in GEHC in Q4 2024 and has held it in 8 quarters since. The position peaked at $514K in Q2 2025. 1,222 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Geneos Wealth Management held 3,402 shares of GE HealthCare worth $222K as of Q3 2026.
  • Geneos Wealth Management bought 1,615 GE HealthCare shares in Q3 2026, an estimated $109K.
  • GE HealthCare made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1052 holding.
  • Geneos Wealth Management first reported a position in GE HealthCare in Q4 2024 and has held it in 8 quarters since.
  • Geneos Wealth Management's GE HealthCare position peaked at $514K in Q2 2025.
  • 1,222 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.